Pharmacokinetics of recombinant human interleukin‐11 (rhIL‐11) in healthy male subjects

Abstract

RhIL-11 demonstrated linear pharmacokinetics at these dose ranges after single and repeated s.c. administration or constant-rate i.v. infusion in healthy volunteers.